C. Haller

发表

Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis‡

C. Stehman-Breen, C. Critchlow, F. Xue, 2013, Pharmacoepidemiology and drug safety.

COMPLEMENTARY AND ALTERNATIVE MEDICINE, NUTRACEUTICALS, AND DIETARY SUPPLEMENTS

C. Haller, 2009 .

Clinical Approach to Adverse Events and Interactions Related to Herbal and Dietary Supplements

C. Haller, 2006, Clinical toxicology.

Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.

N. Benowitz, C. Csajka, D. Verotta, 2005, British Journal of Clinical Pharmacology.

Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements.

N. Benowitz, P. Jacob, C. Haller, 2004, Journal of analytical toxicology.

A novel Blind Start study design to investigate vestronidase alfa for mucopolysaccharidosis VII, an ultra-rare genetic disease.

C. Whitley, P. Harmatz, Raymond Y. Wang, 2018, Molecular genetics and metabolism.

An Evaluation of Selected Herbal Reference Texts and Comparison to Published Reports of Adverse Herbal Events

I. Anderson, P. Blanc, C. Haller, 2002, Adverse drug reactions and toxicological reviews.

Incomplete recovery of prescription opioids in urine using enzymatic hydrolysis of glucuronide metabolites.

A. Wu, C. Haller, J. Stone, 2006, Journal of analytical toxicology.

80 – Weight Reduction Therapies: Anorectants, Thermogenics, and Lipolytics

C. Haller, 2004 .

Prevalence of smoking assessed biochemically in an urban public hospital: a rationale for routine cotinine screening.

N. Benowitz, A. Wu, P. Jacob, 2009, American journal of epidemiology.

Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids

N. Benowitz, C. Haller, 2000 .

Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers.

J. Mehta, S. Gardner, B. Gurley, 2003, The American journal of cardiology.

Determination of ephedra alkaloid and caffeine concentrations in dietary supplements and biological fluids.

N. Benowitz, P. Jacob, M. Peng, 2004, Journal of analytical toxicology.

Hemodynamic effects of ephedra-free weight-loss supplements in humans.

N. Benowitz, P. Jacob, C. Haller, 2005, The American journal of medicine.

Pharmacology of ephedra alkaloids and caffeine after single‐dose dietary supplement use

N. Benowitz, P. Jacob, C. Haller, 2002, Clinical pharmacology and therapeutics.

Photosensitivity Reaction in a Woman Using an Herbal Supplement Containing Ginseng, Goldenseal, and Bee Pollen

K. Olson, C. Haller, A. Palanisamy, 2003, Journal of toxicology. Clinical toxicology.

Performance Enhancers (Steroids, Creatine, DHEA)

C. Haller, D. Thai, 2007 .

HARMACODYNAMICS AND RUG ACTION hort-term metabolic and hemodynamic ffects of ephedra and guarana ombinations

P. Jacob, C. Haller, 2005 .

Short‐term Metabolic and Hemodynamic Effects of Ephedra and Guarana Combinations

N. Benowitz, P. Jacob, C. Haller, 2005, Clinical pharmacology and therapeutics.

Effect of γ-hydroxybutyrate (GHB) on driving as measured by a driving simulator

N. Benowitz, D. Fiorentino, D. Dempsey, 2018, Psychopharmacology.

Individual heat map assessments demonstrate vestronidase alfa treatment response in a highly heterogeneous mucopolysaccharidosis VII study population

C. Whitley, P. Harmatz, Raymond Y. Wang, 2019, JIMD reports.

Making a diagnosis of herbal-related toxic hepatitis.

J. Dyer, K. Olson, C. Haller, 2002, The Western journal of medicine.

Practical approaches to dose selection for first-in-human clinical trials with novel biopharmaceuticals.

P. Andrews, J. T. Sullivan, J. Tibbitts, 2010, Regulatory toxicology and pharmacology : RTP.

Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial.

A. Shaywitz, B. Schweighardt, C. O’Neill, 2015, Clinical therapeutics.

Gamma-hydroxybutyrate and Ethanol Effects and Interactions in Humans

N. Benowitz, J. Dyer, C. Haller, 2006, Journal of clinical psychopharmacology.

C. Haller, Christine A. Haller, T. Andreasson, 2013 .

Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.

N. Benowitz, N L Benowitz, C. Haller, 2001, The New England journal of medicine.

Laboratory Diagnoses and Drug Screening

J. Osterloh, C. Haller, 2007 .

Multi-domain impact of elosufase alfa in Morquio A syndrome in the pivotal phase III trial.

C. Hendriksz, R. Giugliani, D. Hughes, 2015, Molecular genetics and metabolism.

Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials

Yulan Qi, Jack G. Shi, C. Haller, 2018, Clinical Pharmacokinetics.

Enhanced Stimulant and Metabolic Effects of Combined Ephedrine and Caffeine

N. Benowitz, P. Jacob, C. Haller, 2004, Clinical pharmacology and therapeutics.

Adverse Drug Events Associated with Yohimbine-Containing Products: A Retrospective Review of the California Poison Control System Reported Cases

T. Kearney, C. Haller, Nora Tu, 2010, The Annals of pharmacotherapy.

For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

A. Woolf, Lewis S. Nelson, B. Landzberg, 2022 .

Colchicine-related death presenting as an unknown case of multiple organ failure.

M. Galbo, Michael A. Miller, M. Levsky, 2005, The Journal of emergency medicine.

Dietary supplement adverse events: Report of a one-year poison center surveillance project

N. Benowitz, K. Olson, S. Bent, 2008, Journal of Medical Toxicology.

Adverse Drug Reactions: Moving from Chance to Science

C. Haller, L. James, 2011, Clinical pharmacology and therapeutics.

Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory.

C. Haller, J. Stone, Katherine H Chen, 2006, Journal of analytical toxicology.

Clinical Pharmacology of 1,4‐Butanediol and Gamma‐hydroxybutyrate After Oral 1,4‐Butanediol Administration to Healthy Volunteers

J. Dyer, C. Haller, D. Thai, 2007, Clinical pharmacology and therapeutics.

GHB urine concentrations after single-dose administration in humans.

P. Jacob, J. Dyer, C. Haller, 2007, Journal of analytical toxicology.

St John's wort, depression, and catecholamines

C. Haller, 2004, Clinical pharmacology and therapeutics.

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.

A. Wu, Katherine A. Drake, R. Valdes, 2008, Pharmacogenomics.

Seizures Reported in Association with Use of Dietary Supplements

K. Olson, C. Haller, K. H. Meier, 2005, Clinical toxicology.

Impact of Elosulfase Alfa on Pain in Patients with Morquio A Syndrome over 52 Weeks

John J. Mitchell, A. Shaywitz, V. Sutton, 2017 .

Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials

Yulan Qi, Jack G. Shi, C. Haller, 2018, Clinical Pharmacokinetics.

A novel, randomized, placebo-controlled, blind-start, single-crossover phase 3 study to assess the efficacy and safety of UX003 (rhGUS) enzyme replacement therapy in patients with MPS VII

Karen Jacobs, C. Whitley, P. Harmatz, 2017 .

Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions.

N. Benowitz, P. Jacob, C. Haller, 2008, British journal of clinical pharmacology.

A novel approach to characterization and categorization of infusion reactions associated with ERT using adverse physiology related groups

S. Agarwal, C. Haller, E. Kakkis, 2016 .

Herbal Supplements–Drug Interactions: Scientific and Regulatory Perspectives

C. Haller, 2007 .

Nutraceuticals: Has There Been Any Progress?

C. Haller, 2010, Clinical pharmacology and therapeutics.

Pharmacologic agents for weight reduction.

J. Schwartz, C. Haller, 2002, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.